Smooth Learning from the lessons: Defeat the current pandemic due to the SARS-COV-2 virus as well as any future pandemics using hydro-enrolled dehydrogenase inhibitors (HDHODH)

  • Funded by Ministry of Education, University and Research Italy
  • Total publications:3 publications

Grant number: FISR2020IP_01252

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $67,901.15
  • Funder

    Ministry of Education, University and Research Italy
  • Principal Investigator

    N/A

  • Research Location

    Italy
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

The US21 viroporin of human cytomegalovirus stimulates cell migration and adhesion.

The Novel hDHODH Inhibitor MEDS433 Prevents Influenza Virus Replication by Blocking Pyrimidine Biosynthesis.

The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses.